CIK 0000109657 · Non-accelerated filer<br>Smaller reporting company
GT Biopharma, Inc.
Sign in to watch- Ticker
- GTBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 941620407
- Phone
- (800) 304-9888
- Business address
- 505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
- Former names
- GT Biopharma, Inc., OXIS INTERNATIONAL INC
- 8-K Event Debt accelerated · Executive or director change
- 424B3 Offering Prospectus
- 10QSB Other 10QSB
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 424B3 Offering Prospectus
- 8-K Event Material agreement · New debt or obligation
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- UPLOAD Other SEC-generated Letter
- PRE 14A Proxy Proxy Statement (Preliminary)
- 424B3 Offering Prospectus
- 8-K Event Material agreement
Page 32 of 45 · 884 filings